Syntara (ASX:SNT) 3-Year Book Growth Rate : 48.10% (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Syntara 3-Year Book Growth Rate?

Syntara's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.01.

During the past 12 months, Syntara's average Book Value per Share Growth Rate was -63.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was 48.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -16.90% per year. During the past 10 years, the average Book Value per Share Growth Rate was -25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Syntara was 48.10% per year. The lowest was -44.40% per year. And the median was -19.80% per year.

Competitive Comparison of Syntara's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Syntara's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Syntara's 3-Year Book Growth Rate falls into.

Syntara 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Syntara (ASX:SNT) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Syntara 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Syntara's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Syntara (ASX:SNT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

UUDA:Germany

Address

20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086

Website

https://www.pharmaxis.com.au

Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.